![]() |
Sign Up! | Tags | Domains | Statistics | Options | Advanced Search |
injuryboard.com » InjuryBoard National News Desk - Nov 13, 2008
LEARN MORE FDA's MedWatch 1-800-332-1088 NEJM, May 2007 on Atrial Fibrillation Injuryboard on Pfizer osteoporosis drug, September 2008 NIH on vitamin D U.S.D.A. on vitamin D foods Injuryboard on sunshine and …
Also tagged: dangerous drugs, fda and prescription drugs, major medical, protecting your family
imt.ie » IMT Clinical Times - Nov 11, 2008
In our new bi-monthly series, Irish Medical Times — in association with MSD Science Centre — has asked general practitioners to submit questions for consultants to answer. Here, Prof JB Walsh responds to GPs’ …
Also tagged: musculoskeletal
![]() |
Calcium and vitamin D important for active womenkoeln.de » That's Fit - Nov 10, 2008 Filed under: Food and Nutrition, Women's Health It's a well-known fact that older women need calcium and vitamin D to fight bone loss. But it's also important that younger, active women get calcium and vitamin D to … Also tagged: supplements, milk, supplement, calcium, bone, dairy, vitamin d, vitamind, bone density, bone growth, stress fracture |
telegraph.co.uk » Telegraph Food and Drink - Nov 10, 2008
Bee Wilson on the baby blues.
Also tagged: health, diet, nigel denby, bee wilson, moulds, unpasteurised cheese
northcountrygazette.org » North Country Gazette - Nov 2, 2008
WASHINGTON, DC—The U.S. Food and Drug Administration has sent warning letters to Bayer HealthCare concerning two unlawful, over-the-counter (OTC) aspirin products — Bayer Women’s Low Dose Aspirin + Calcium (Bayer …
Also tagged: business, health, drugs, government, heart, letters, fda, bayer, aspirin, calcium, consumers, nationwide, dietary supplement, pain reliever
![]() |
Amgen Scientist, After 13-Year Push, Sees Bone Cancer Work Paying Dividendsxconomy.com » Xconomy Life Sciences Feed - Oct 29, 2008 Biotech, cancer, Denosumab Luke Timmerman wrote: Amgen had the worst year in its history in 2007, according to CEO Kevin Sharer. If you’re wondering why the world’s largest biotech company has mounted a comeback this … Also tagged: cancer, seattle, biotech, amgen, university of pennsylvania, san antonio breast cancer symposium, genentech, avastin, aranesp, epogen, rheumatoid arthritis, enbrel, carol pawlak, national blog main, seattle blog main, immunex, rodman and 38 renshaw, denosumab, rank ligand, american society of bone and mineral research, kevin sharer, bill dougall, scott simonet, dave lacey, christopher james |
![]() |
Amgen Scientist, After 13-Year Push, Sees Bone Cancer Work Paying Dividendsxconomy.com » Xconomy - Oct 28, 2008 Biotech, cancer, Denosumab Luke Timmerman wrote: Amgen had the worst year in its history in 2007, according to CEO Kevin Sharer. If you’re wondering why the world’s largest biotech company has mounted a comeback this … Also tagged: cancer, seattle, biotech, amgen, university of pennsylvania, san antonio breast cancer symposium, genentech, avastin, aranesp, epogen, rheumatoid arthritis, enbrel, carol pawlak, national blog main, seattle blog main, immunex, rodman and 38 renshaw, denosumab, rank ligand, american society of bone and mineral research, kevin sharer, bill dougall, scott simonet, dave lacey, christopher james |
injuryboard.com » InjuryBoard National News Desk - Oct 28, 2008
LEARN MORE American Herbal Products Association Bayer on aspirin therapy Bayer Heart Advantage Bayer Woman's low dose aspirin FDA letter Injuryboard news on cholesterol IMAGE SOURCE: Bayer Heart Advantage web …
Also tagged: heart attack, cholesterol, bayer, aspirin, fda and prescription drugs, major medical, protecting your family
injuryboard.com » InjuryBoard National News Desk - Oct 28, 2008
LEARN MORE InjuryBoard on Osteoporosis InjuryBoard on Bone, Joint & Muscle Disorders InjuryBoard on Strokes WebMD on Bisphosphonate Drugs Bisphosphonates for Osteoporosis Treatment Linked to Jawbone Damage …
Also tagged: merck, stroke, bisphosphonates, atrial fibrillation, reclast, fda and prescription drugs, major medical, fosomax
telegraph.co.uk » Telegraph News - Oct 27, 2008
A row has broken out over restrictions on drugs to prevent women with weak bones from suffering fractures.
Also tagged: nice, fracture, alendronate, national institute for health and clinical excelle, national osteoporosis society, professor peter littlejohns, nick rijke